An Oncologic Surgeon specializes in the surgical treatment of cancer, playing a critical role in diagnosing, staging, and removing tumors to improve patient outcomes. They perform complex procedures such as tumor resections, lymph node dissections, and organ reconstructions to eliminate cancerous tissues while preserving function. With advancements in minimally invasive and robotic-assisted techniques, oncologic surgeons can now offer more precise, less invasive procedures that enhance recovery and reduce complications. They work closely with oncologists, radiologists, and pathologists to develop comprehensive treatment plans, often integrating surgery with chemotherapy and radiation therapy. Specializing in areas like breast cancer, gastrointestinal cancers, and sarcomas, oncologic surgeons help improve survival rates and quality of life for cancer patients. Ongoing research and innovations in surgical oncology, such as targeted therapies and immunotherapy, continue to refine cancer treatment, making surgical interventions more effective and personalized for each patient’s needs.
Title : Microbial spectrum and histo-pathological pattern in patients with breast abscess: A 5 year retrospective study in a tertiary care rural teaching hospital in South India
Caroline Francis, Hull Royal Infirmary, United Kingdom
Title : Evolution of surgical oncology
Nagy Habib, Imperial College London, United Kingdom
Title : Cell therapy for chronic ischemia
Darwin Eton, Vasogenesis Inc, United States
Title : Improving post-operative analgesia regimens after emergency major abdominal surgery
Shifa Bangi, Oxford University Hospitals NHS Trust, United Kingdom
Title : The coincidence between spinal perineural cysts, increased intracranial pressure and the appearance of small fiber neuropathy. Exploring the relationship and (surgical) lessons to be learned
Ricky Rasschaert, AZ Rivierenland, Belgium
Title : Predicting reductions in acute pain and opioid consumption with non-opioid analgesics: A machine learning analysis of randomised controlled trials (OPERA study)
Toluwalogo Daramola, University of Nottingham, United Kingdom